Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
AGMB Insider Trading and Fund Holdings (AgomAb Therapeutics NV) · https://wallstpal.com/stock/agmb/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 2020932

AgomAb Therapeutics NV (AGMB): Insider Trades and Fund Holdings

In the past 12 months, AgomAb Therapeutics NV insiders reported 7 open-market purchases worth $400K and no sales.

7Insider buys, 12 months
$400KBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.

  1. Oct 21, 2026Insider buyDirector David R. Epstein bought $88,800
  2. Oct 8, 2026Insider buyDirector David R. Epstein bought $44,500
  3. Oct 6, 2026Insider buyCFO Pierre Thadee Victor Kemula bought $85,940
  4. Oct 6, 2026Insider buyDirector David R. Epstein bought $43,500
  5. Oct 6, 2026Insider buyCEO Tim Jasper Knotnerus bought $43,500
  6. Oct 5, 2026Insider buyCEO Tim Jasper Knotnerus bought $50,880
  7. Oct 5, 2026Insider buyDirector David R. Epstein bought $42,850

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 22, 2026.

Recent AGMB insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 22Oct 21David R. EpsteinDirectorDirector▲ BUY10,0008.88$89K+67%Form 4 ↗
Oct 9Oct 8David R. EpsteinDirectorDirector▲ BUY5,0008.90$45K+50%Form 4 ↗
Oct 7Oct 6Pierre Thadee Victor KemulaCFOCFO▲ BUY10,0008.59$86KNewForm 4 ↗
Oct 7Oct 5Tim Jasper KnotnerusCEOCEO▲ BUY6,0008.48$51K+55%Form 4 ↗
Oct 7Oct 6David R. EpsteinDirectorDirector▲ BUY5,0008.70$44K+100%Form 4 ↗
Oct 7Oct 6Tim Jasper KnotnerusCEOCEO▲ BUY5,0008.70$44K+30%Form 4 ↗
Oct 7Oct 5David R. EpsteinDirectorDirector▲ BUY5,0008.57$43KNewForm 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
David R. EpsteinDirector4$220K0$0Oct 22, 2026
Pierre Thadee Victor KemulaCFO1$86K0$0Oct 7, 2026
Tim Jasper KnotnerusCEO2$94K0$0Oct 7, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →